Jonas Dyhrfjeld-Johnsen, based in Tübingen, BW, DE, is currently a Chief Development Officer and Managing Director at Acousia Therapeutics GmbH, bringing experience from previous roles at Rewind Therapeutics, Sensorion and SENSORION. Jonas Dyhrfjeld-Johnsen holds a 1999 - 2004 Ph.D. in Biology/Neuroscience @ Heinrich-Heine-Universität Düsseldorf. With a robust skill set that includes Neuroscience, In Vivo, Experimentation, Modeling, Biophysics and more, Jonas Dyhrfjeld-Johnsen contributes valuable insights to the industry. Jonas Dyhrfjeld-Johnsen has 2 emails on RocketReach.